Regeneron Pharmaceuticals
Regeneron is seeking a Program Manager to lead and facilitate cross‑functional collaboration for antibody platform development and engineering projects. The role independently drives complex programs, manages interdependencies, and champions process improvements while aligning with organizational priorities.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
44% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Group Leader of Antibody Engineering
Roche
Associate Director of Antibody Discovery Programs
Alloy Therapeutics
Antibody Drug Discovery Lead
C0003153479P
Senior Scientist/Scientist, Antibody Engineering & Biologics
ASTARPRD
Scientific Director, Bioconjugation Development
Neurocrine Biosciences
Director, (Senior Principal Scientist) Antibody Generation and Engineering
City of Duncan, Oklahoma